Purpose Inpatient palliative care integrated with transplant care improves patients' quality of
life (QOL) and symptom burden during hematopoietic stem-cell transplant (HCT). We …

Importance During hospitalization for hematopoietic stem cell transplantation (HCT), patients
receive high-dose chemotherapy before transplantation and experience significant physical …

BACKGROUND During hospitalization for hematopoietic stem cell transplantation (HCT),
patients experience a steep deterioration in quality of life (QOL) and mood. To our …

BACKGROUND We conducted a study to investigate the impact of hospitalization for
hematopoietic stem cell transplantation (HCT) on the quality of life (QOL) and mood of …

BACKGROUND To evaluate the impact of depression before autologous and allogeneic
hematopoietic cell transplantation (HCT) on clinical outcomes post‐transplantation …

Purpose This study examined quality of life, transplant-related concerns, and depressive
symptoms and their demographic and medical correlates at 1 to 3 years following …

Background In recent decades, advances in transplantation medicine, and improved
posttransplant care have reduced morbidity and mortality from hematopoietic stem cell …

Purpose The study aims to evaluate the mediating effect of depressive symptoms on the
relationship between physical symptoms and health-related quality of life (HRQOL) in …

Multiple diverse biomedical variables have been shown to affect outcome after
hematopoietic stem cell transplantation (HSCT). Whether psychosocial variables should be …

BACKGROUND Patients treated with hematopoietic cell transplantation (HCT) often
experience depression and fatigue but analyses to determine risk factors have typically …